For citations:
Andreeva T.A., Davydkin I.L., Mamaev A.N., Vdovin V.V., Lavrichenko I.A., Konstantinova V.N., Klimova N.I., Kurtov I.V., Shamina M.S., Momot A.P., Belozerov D.Ye., Svirin P.V., Shiller E.E., Shuster A.M., Kudlay D.A. Results of a multicenter, prospective, open, uncontrolled study of the efficacy and safety of the drug Innonafactor in patients aged 12 years and older with severe and moderate hemophilia B. Russian Journal of Pediatric Hematology and Oncology. 2017;4(4):20-32. (In Russ.) https://doi.org/10.17650/2311-1267-2017-4-4-20-32
Email this article 